Currently Viewing:
Currently Reading
AJMC® in the Press, January 4, 2019
January 04, 2019 – AJMC Staff
Abemaciclib Plus Endocrine Therapy May Benefit Patients With Certain Characteristics
December 28, 2018 – David Bai, PharmD
Chemotherapy for Solid Tumors Associated With Increased Risk of AML, MDS
December 28, 2018 – Laura Joszt
Top 5 Most-Read AJMC® Research of 2018
December 28, 2018 – Christina Mattina
This Year in Managed Care: 2018 Recap
December 28, 2018
Males With MPN Have More Aggressive Disease Biology, Independent of Other Factors
December 27, 2018 – Jackie Syrop
Challenges and Opportunities in the Oncology Care Model
December 23, 2018 – Laura Joszt
AJMC® in the Press, December 21, 2018
December 21, 2018 – AJMC Staff
Diabetes, Cancer Interviews Among Most-Watched Videos of 2018
December 20, 2018 – Laura Joszt

AJMC® in the Press, January 4, 2019

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
This month’s issue of The American Journal of Managed Care® (AJMC®) includes a study on hospital advertising expenditures, which was highlighted in Becker’s Hospital Review and Health IT Security. The study, “Understanding the Relationship Between Data Breaches and Hospital Advertising Expenditures,” found that a hospital data breach was associated with a 64% increase in annual advertising expenditures. The researchers concluded that efforts to repair the hospital’s image and minimize patient loss to competitors are potential drivers of the increased spending. The study was also included in POLITICO's Friday Morning eHealth.

An article from AJMC® was included in the National Pharmaceutical Council’s Wednesday CER Daily Newsfeed. The article, “Pembrolizumab Superior to Standard of Care in SCC,” covered study findings that determined that among patients with head and neck squamous cell carcinoma, overall survival when treated with pembrolizumab was superior to standard doses of methotrexate, docetaxel, and cetuximab.

The newsfeed also included an AJMC® interview with Robert Daly, MD, MBA, medical oncologist, Memorial Sloan Kettering Cancer Center. During the interview, Daly discussed how clinical pathways can reduce disparities in breast cancer.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up